PRINSTON INC FDA Approval ANDA 210608

ANDA 210608

PRINSTON INC

FDA Drug Application

Application #210608

Application Sponsors

ANDA 210608PRINSTON INC

Marketing Status

Prescription001

Application Products

001TABLET;ORAL20MG0TADALAFILTADALAFIL

FDA Submissions

UNKNOWN; ORIG1AP2022-08-11STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB2

CDER Filings

PRINSTON INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210608
            [companyName] => PRINSTON INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"TADALAFIL","activeIngredients":"TADALAFIL","strength":"20MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/11\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-08-11
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.